About: MMDA (drug)

Property	Value
dbo:abstract	MMDA (3-methoxy-4,5-methylenedioxyamphetamine; 5-methoxy-MDA) is a psychedelic and entactogen drug of the amphetamine class. It is an analogue of lophophine, MDA, and MDMA. MMDA was described by Alexander Shulgin in his book PiHKAL. Shulgin lists the dosage range of MMDA as 100–250 mg. The first effects appear within 30–60 minutes following oral administration. MMDA produces euphoria and loving warmth, and attenuates feelings such as anxiety and loneliness. MMDA also produces closed eye visuals, a state of drowsiness, muscle relaxation, and time distortion. Side effects include moderate mydriasis, dizziness, sensations of heat or cold, and trembling. The imagery is generally realistic, and often related to everyday perception of people, landscapes, or objects. The effects of MMDA usually reach a peak during the first hour following the initial effects, and begin to wane during the second hour, and usually completely disappear by the end of the fifth hour. (en) L'MMDA(noto come 3-metossi-4,5-metilendiossiamfetamina o come 5-metossi-MDA) è una droga psichedelica ed empatogeni della classe delle anfetamine. Ha formula chimica C11H15NO3. (it) MMDA, 3-metoksy-4,5-metylenodioksyamfetamina – organiczny związek chemiczny z grupy amfetamin, psychodelik i empatogen, występuje w postaci dwóch enancjomerów. Została opisana przez Alexandra Shulgina w PiHKAL. Dawkowanie MMDA wynosi od 100–250 mg, a pierwsze efekty zaczynają się około 30–60 minut po podaniu doustnym. MMDA wywołuje euforię, uczucie ciepła, łagodzi lęk i poczucie samotności. Powoduje także lekkie zmiany percepcji. Do efektów ubocznych można zaliczyć m.in. senność i zawroty głowy. Jest sklasyfikowana w Polsce jako substancja psychotropowa grupy I-P. (pl) MMDA (3-метокси-4,5-метилендиоксиамфетамин) — химическое соединение класса амфетаминов, эмпатоген и психоделик. Типичная оральная доза составляет 100—250 мг. (ru)
dbo:casNumber	13674-05-0
dbo:fdaUniiCode	RG7FY73ZAA
dbo:pubchem	26175
dbo:thumbnail	wiki-commons:Special:FilePath/MMDA-structure.png?width=300
dbo:wikiPageExternalLink	http://pihkal.info/read.php%3Fdomain=pk&id=132 http://www.erowid.org/archive/rhodium/chemistry/mmda.pharmacology.shulgin.html http://www.erowid.org/archive/rhodium/chemistry/mmda.shulgin.html http://www.erowid.org/library/books_online/pihkal/pihkal132.shtml http://www.erowid.org/references/refs_view.php%3FA=ShowDoc1&ID=3598
dbo:wikiPageID	3317291 (xsd:integer)
dbo:wikiPageLength	6244 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1119176014 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Psychotherapeutic dbr:Mood_(psychology) dbr:Mouth dbr:Perception dbr:Insufflation_(medicine) dbr:Structural_analog dbr:Substituted_amphetamine dbr:Psychedelic_drug dbr:Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons dbc:Benzodioxoles dbc:Designer_drugs dbc:Entactogens_and_empathogens dbc:Phenol_ethers dbc:Serotonin_receptor_agonists dbc:Serotonin_releasing_agents dbr:Controlled_Substances_Act dbr:Mental_image dbr:Claudio_Naranjo dbr:Mydriasis dbr:Convention_on_Psychotropic_Substances dbr:Rectal dbr:Anxiety dbr:Lophophine dbr:MDMA dbr:Communication dbr:Trimethoxyamphetamine dbr:Muscle_relaxant dbr:Drug dbr:Euphoria_(emotion) dbr:Loneliness dbr:3,4-Methylenedioxyamphetamine dbr:Agonist dbr:Alexander_Shulgin dbr:5-HT2A_receptor dbr:Norepinephrine dbc:Substituted_amphetamines dbr:Adverse_drug_reaction dbr:Drowsiness dbr:Imagery_analysis dbr:Dizziness dbr:Dopamine dbr:Empathogenic dbr:Entactogen dbr:Neurotoxic dbr:Serotonin_releasing_agent dbr:Psychotherapy dbr:PiHKAL dbr:Trembling dbr:Hot_flashes dbr:Wiktionary:oral dbr:Peak_experiences
dbp:atcPrefix	none (en)
dbp:c	11 (xsd:integer)
dbp:casNumber	13674 (xsd:integer)
dbp:chemspiderid	24386 (xsd:integer)
dbp:drugName	MMDA (en)
dbp:h	15 (xsd:integer)
dbp:iupacName	1 (xsd:integer)
dbp:legalAu	Schedule 9 (en)
dbp:legalCa	Schedule I (en)
dbp:legalDe	Anlage I (en)
dbp:legalUk	Class A (en)
dbp:legalUn	P I (en)
dbp:legalUs	Schedule I (en)
dbp:n	1 (xsd:integer)
dbp:o	3 (xsd:integer)
dbp:pubchem	26175 (xsd:integer)
dbp:routesOfAdministration	dbr:Mouth dbr:Insufflation_(medicine) dbr:Rectal
dbp:smiles	O1c2ccCCC (en)
dbp:unii	RG7FY73ZAA (en)
dbp:wikiPageUsesTemplate	dbt:As_of dbt:Drugbox dbt:Entactogens dbt:Monoamine_releasing_agents dbt:More_citations_needed dbt:Phenethylamines dbt:Reflist dbt:Serotonin_receptor_modulators dbt:Short_description dbt:Fdacite
dct:subject	dbc:Benzodioxoles dbc:Designer_drugs dbc:Entactogens_and_empathogens dbc:Phenol_ethers dbc:Serotonin_receptor_agonists dbc:Serotonin_releasing_agents dbc:Substituted_amphetamines
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Abstraction100002137 yago:Element114840755 yago:Matter100020827 yago:Part113809207 yago:PhysicalEntity100001930 yago:Quintessence114847103 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:WikicatPhenolEthers umbel-rc:ChemicalSubstanceType
rdfs:comment	L'MMDA(noto come 3-metossi-4,5-metilendiossiamfetamina o come 5-metossi-MDA) è una droga psichedelica ed empatogeni della classe delle anfetamine. Ha formula chimica C11H15NO3. (it) MMDA, 3-metoksy-4,5-metylenodioksyamfetamina – organiczny związek chemiczny z grupy amfetamin, psychodelik i empatogen, występuje w postaci dwóch enancjomerów. Została opisana przez Alexandra Shulgina w PiHKAL. Dawkowanie MMDA wynosi od 100–250 mg, a pierwsze efekty zaczynają się około 30–60 minut po podaniu doustnym. MMDA wywołuje euforię, uczucie ciepła, łagodzi lęk i poczucie samotności. Powoduje także lekkie zmiany percepcji. Do efektów ubocznych można zaliczyć m.in. senność i zawroty głowy. Jest sklasyfikowana w Polsce jako substancja psychotropowa grupy I-P. (pl) MMDA (3-метокси-4,5-метилендиоксиамфетамин) — химическое соединение класса амфетаминов, эмпатоген и психоделик. Типичная оральная доза составляет 100—250 мг. (ru) MMDA (3-methoxy-4,5-methylenedioxyamphetamine; 5-methoxy-MDA) is a psychedelic and entactogen drug of the amphetamine class. It is an analogue of lophophine, MDA, and MDMA. MMDA was described by Alexander Shulgin in his book PiHKAL. Shulgin lists the dosage range of MMDA as 100–250 mg. The first effects appear within 30–60 minutes following oral administration. MMDA produces euphoria and loving warmth, and attenuates feelings such as anxiety and loneliness. MMDA also produces closed eye visuals, a state of drowsiness, muscle relaxation, and time distortion. Side effects include moderate mydriasis, dizziness, sensations of heat or cold, and trembling. The imagery is generally realistic, and often related to everyday perception of people, landscapes, or objects. The effects of MMDA usually r (en)
rdfs:label	MMDA (it) MMDA (drug) (en) MMDA (pl) MMDA (ru)
owl:sameAs	freebase:MMDA (drug) yago-res:MMDA (drug) wikidata:MMDA (drug) dbpedia-fa:MMDA (drug) dbpedia-it:MMDA (drug) dbpedia-pl:MMDA (drug) dbpedia-ru:MMDA (drug) dbpedia-sh:MMDA (drug) dbpedia-sr:MMDA (drug) https://global.dbpedia.org/id/3izPg
prov:wasDerivedFrom	wikipedia-en:MMDA_(drug)?oldid=1119176014&ns=0
foaf:depiction	wiki-commons:Special:FilePath/MMDA-structure.png
foaf:isPrimaryTopicOf	wikipedia-en:MMDA_(drug)
foaf:name	MMDA (en)
is dbo:wikiPageDisambiguates of	dbr:MMDA
is dbo:wikiPageRedirects of	dbr:4T-MMDA-2 dbr:MMDA-3a dbr:MMDA-3b dbr:2T-MMDA-3a dbr:Methoxymethylenedioxyamphetamine dbr:3-MeO-4,5-MDA dbr:3-Methoxy-4,5-methylendioxyamphetamine dbr:3-Methoxy-4,5-methylenedioxyamphetamine dbr:3-methoxy-4,5-Methylenedioxyamphetamine dbr:3-methoxy-4,5-methylendioxyamphetamine dbr:3-methoxy-4,5-methylenedioxy-phenylisopropylamine dbr:3-methoxy-4,5-methylenedioxyamphetamine dbr:4,5-methylenedioxy-3-methoxyamphetamine dbr:5-methoxy-3,4-methylenedioxyamphetamine dbr:1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine dbr:MMDA_(psychedelic)
is dbo:wikiPageWikiLink of	dbr:4T dbr:4T-MMDA-2 dbr:List_of_designer_drugs dbr:Oneirogen dbr:MMDA-3a dbr:MMDA-3b dbr:Myristicin dbr:Convention_on_Psychotropic_Substances dbr:Lophophine dbr:MDMA dbr:Mad_Dogs_(British_TV_series) dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:2T-MMDA-3a dbr:Methoxymethylenedioxyamphetamine dbr:MMDA dbr:Substituted_phenethylamine dbr:PiHKAL dbr:3-MeO-4,5-MDA dbr:3-Methoxy-4,5-methylendioxyamphetamine dbr:3-Methoxy-4,5-methylenedioxyamphetamine dbr:3-methoxy-4,5-Methylenedioxyamphetamine dbr:3-methoxy-4,5-methylendioxyamphetamine dbr:3-methoxy-4,5-methylenedioxy-phenylisopropylamine dbr:3-methoxy-4,5-methylenedioxyamphetamine dbr:4,5-methylenedioxy-3-methoxyamphetamine dbr:5-methoxy-3,4-methylenedioxyamphetamine dbr:1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine dbr:MMDA_(psychedelic)
is foaf:primaryTopic of	wikipedia-en:MMDA_(drug)